ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 702359 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 702359; 2) Community: the network communities that were significantly associated with the response to NSC 702359; 3) Molecule: the relationships between components within communities and NSC 702359; 4) MDR: the compounds that were significantly associated with the NSC 702359.

NSC Compound Enrichment Correlation
NSC 105132 Deoxycamptothecin 0.0137891122538509 0.30836997
NSC 132277 Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) 0.0137891122538509 0.22791618
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.0137891122538509 0.12920787
NSC 13484 Null 0.0137891122538509 0.25826455
NSC 135073 WITHACNISTIN 0.0137891122538509 0.32515838
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.0137891122538509 0.32222992
NSC 28608 Null 0.0137891122538509 0.33622362
NSC 326061 1-Piperidinecarbothioic acid, 2-ethyl-, [1-(2-pyridinyl)ethylidine]hydrazide 0.0137891122538509 0.23879061
NSC 350629 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester 0.0137891122538509 0.24352995
NSC 382032 Null 0.0137891122538509 0.30940241
Total:112  Current:39    [First] [Prev] [Next] [Last]